Cullinan Therapeutics (CGEM) Change in Acquisitions & Divestments: 2020-2024
Historic Change in Acquisitions & Divestments for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to $584.8 million.
- Cullinan Therapeutics' Change in Acquisitions & Divestments fell 11.40% to $117.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $409.4 million, marking a year-over-year increase of 16.00%. This contributed to the annual value of $584.8 million for FY2024, which is 42.85% up from last year.
- Cullinan Therapeutics' Change in Acquisitions & Divestments amounted to $584.8 million in FY2024, which was up 42.85% from $409.4 million recorded in FY2023.
- In the past 5 years, Cullinan Therapeutics' Change in Acquisitions & Divestments registered a high of $584.8 million during FY2024, and its lowest value of $62.9 million during FY2020.
- Over the past 3 years, Cullinan Therapeutics' median Change in Acquisitions & Divestments value was $409.4 million (recorded in 2023), while the average stood at $449.0 million.
- Data for Cullinan Therapeutics' Change in Acquisitions & Divestments shows a peak YoY surged of 205.29% (in 2021) over the last 5 years.
- Over the past 5 years, Cullinan Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $62.9 million in 2020, then soared by 205.29% to $192.0 million in 2021, then skyrocketed by 83.78% to $352.9 million in 2022, then grew by 16.00% to $409.4 million in 2023, then skyrocketed by 42.85% to $584.8 million in 2024.